{"title":"Clinical Outcomes in Women with Breast Implant Illness After Removal Surgery: Experience from a Latin American Center.","authors":"Paola Kafury-Goeta, Viviana García, Alvaro Villegas, Nora B Sánchez, Federico Reina","doi":"10.1007/s00266-025-05298-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To investigate the impact of removal surgery in women with breast implant illness (BII) on the improvement of symptoms, as well as on the current quality of life of women.</p><p><strong>Methods: </strong>This is an observational study of a cohort of women undergoing definitive implant removal for BII-related symptomatology between 2016 and 2022 in Cali, Colombia. All data were collected from medical records and through a telephone survey. The severity of 10 clinical manifestations before and after removal surgery was evaluated with a five-point Likert scale. Quality of life was assessed with the BREAST-Q scale.</p><p><strong>Results: </strong>A total of 125 women who underwent breast removal surgery were included; mean age was 48.8 ±9.7 years. The three most frequent reported symptoms at baseline were sore/aching joint (48.0%), fatigue (32.0%), and hair loss (25.6%). At a median follow-up of 18 months after implant removal, significant improvement was observed in all symptoms (p value<0.05) with a mean reduction in the percentage of women with symptomatology of 55.8% ±6.4%. At least half of the women reported a BREAST-Q of 100 points on the dimensions of satisfaction with breasts, physical well-being, and satisfaction with surgical outcome.</p><p><strong>Conclusion: </strong>This study provides evidence in favor of breast removal surgery as a treatment option in women with BII symptomatology. Highlights Nowadays, the evidence on breast implant illness is not conclusive. However, due to media interest and growing concern among patients and decision-makers, it is necessary to increase knowledge about BII, especially in low- and middle-income countries where evidence is poor. Consistent with the results of other studies, implant removal surgery significantly reduced the severity of symptoms at a median follow-up of 18 months after explantation in 125 women included in this study. Women after explantation reported a good quality of life and satisfaction with their breast appearance, physical well-being and surgical outcome with the BREAST-Q score.</p><p><strong>Level of evidence iv: </strong>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .</p>","PeriodicalId":7609,"journal":{"name":"Aesthetic Plastic Surgery","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aesthetic Plastic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00266-025-05298-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To investigate the impact of removal surgery in women with breast implant illness (BII) on the improvement of symptoms, as well as on the current quality of life of women.
Methods: This is an observational study of a cohort of women undergoing definitive implant removal for BII-related symptomatology between 2016 and 2022 in Cali, Colombia. All data were collected from medical records and through a telephone survey. The severity of 10 clinical manifestations before and after removal surgery was evaluated with a five-point Likert scale. Quality of life was assessed with the BREAST-Q scale.
Results: A total of 125 women who underwent breast removal surgery were included; mean age was 48.8 ±9.7 years. The three most frequent reported symptoms at baseline were sore/aching joint (48.0%), fatigue (32.0%), and hair loss (25.6%). At a median follow-up of 18 months after implant removal, significant improvement was observed in all symptoms (p value<0.05) with a mean reduction in the percentage of women with symptomatology of 55.8% ±6.4%. At least half of the women reported a BREAST-Q of 100 points on the dimensions of satisfaction with breasts, physical well-being, and satisfaction with surgical outcome.
Conclusion: This study provides evidence in favor of breast removal surgery as a treatment option in women with BII symptomatology. Highlights Nowadays, the evidence on breast implant illness is not conclusive. However, due to media interest and growing concern among patients and decision-makers, it is necessary to increase knowledge about BII, especially in low- and middle-income countries where evidence is poor. Consistent with the results of other studies, implant removal surgery significantly reduced the severity of symptoms at a median follow-up of 18 months after explantation in 125 women included in this study. Women after explantation reported a good quality of life and satisfaction with their breast appearance, physical well-being and surgical outcome with the BREAST-Q score.
Level of evidence iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
期刊介绍:
Aesthetic Plastic Surgery is a publication of the International Society of Aesthetic Plastic Surgery and the official journal of the European Association of Societies of Aesthetic Plastic Surgery (EASAPS), Società Italiana di Chirurgia Plastica Ricostruttiva ed Estetica (SICPRE), Vereinigung der Deutschen Aesthetisch Plastischen Chirurgen (VDAPC), the Romanian Aesthetic Surgery Society (RASS), Asociación Española de Cirugía Estética Plástica (AECEP), La Sociedad Argentina de Cirugía Plástica, Estética y Reparadora (SACPER), the Rhinoplasty Society of Europe (RSE), the Iranian Society of Plastic and Aesthetic Surgeons (ISPAS), the Singapore Association of Plastic Surgeons (SAPS), the Australasian Society of Aesthetic Plastic Surgeons (ASAPS), the Egyptian Society of Plastic and Reconstructive Surgeons (ESPRS), and the Sociedad Chilena de Cirugía Plástica, Reconstructiva y Estética (SCCP).
Aesthetic Plastic Surgery provides a forum for original articles advancing the art of aesthetic plastic surgery. Many describe surgical craftsmanship; others deal with complications in surgical procedures and methods by which to treat or avoid them. Coverage includes "second thoughts" on established techniques, which might be abandoned, modified, or improved. Also included are case histories; improvements in surgical instruments, pharmaceuticals, and operating room equipment; and discussions of problems such as the role of psychosocial factors in the doctor-patient and the patient-public interrelationships.
Aesthetic Plastic Surgery is covered in Current Contents/Clinical Medicine, SciSearch, Research Alert, Index Medicus-Medline, and Excerpta Medica/Embase.